The autologous platelet-rich plasma (PRP) gel, rich in growth factors such as vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF), epidermal growth factor (EGF), etc., is considered to be a promising approach for the treatment of diabetic foot ulcers due to absence of immunological reaction, acceleration of cell proliferation and wound tissues’ migration. Here, VEGFA is linked to diabetic foot.